CClinicalTrials.gg
CompletedNCT01542593URO-Y-2Updated Apr 30, 2015

Evaluating Ureteral Length Using Computed Tomography (CT)

An interventional study of Ureteral catheterization - Cook Urological Inc. open end ureteral catheter 5FR in Ureteral Calculi, Hydronephrosis and Ureteral Obstruction, sponsored by Carmel Medical Center. Completed at 1 site in Israel. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2015-04-30.

Sponsored by Carmel Medical Center · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
53
Allocation
Not applicable
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Proper selection of ureteral stent length might help in reducing comorbidities associated with ureteral stenting, currently there is no standardized way of measuring ureteral length.

Measurement of ureteral length according to Computed Tomography (CT) scan might provide useful information when selecting the length of a ureteral stent. Our aim in this study is to compare ureteral measurements using CT scan and measurement of actual ureteral length measured during ureteral stenting.

02

Conditions studied

  • Ureteral Calculi
  • Hydronephrosis
  • Ureteral Obstruction
03

In context

Hydronephrosis

64 studies on the registry are indexed under Hydronephrosis; 12 are open to participants now.

This study's enrollment of 53 is close to the median of 54 across 34 interventional studies indexed under Hydronephrosis.

Browse Hydronephrosis studies →

Lead sponsor

Carmel Medical Center is the lead sponsor of 112 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients undergoing planned procedure involving ureteroscopy or ureteral stenting
  • Abdominal CT scan performed within 6 months prior to intervention

Exclusion criteria

Exclusion Criteria:

  • Known iodine sensitivity
  • Patients with fever or hemodynamic instability planned for urgent operation
  • Severe immune compromized patients
  • Severe thrombocytopenia \< 50,000
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
53 participants (actual)

Study arms

  • Experimental
    Ureteral catheterization

    During a planned procedure involving ureteroscopy or ureteral stenting, ureteral catheterization will be performed for the purpose of measuring exact ureteral length. Measurement results will be compared to measurements performed on CT scan (obtained before surgery).

    Device: Ureteral catheterization - Cook Urological Inc. open end ureteral catheter 5FR

Interventions

  • DeviceUreteral catheterization - Cook Urological Inc. open end ureteral catheter 5FR

    During a planned procedure involving ureteroscopy or ureteral stenting, after retrograde pyelography and insertion of a safety wire, ureteral catheterization will be performed using Cook Urological Inc. open end ureteral catheter 5FR for the purpose of measuring exact ureteral length. Measurement results will be compared to measurements performed on CT scan (obtained before surgery).

    Also known as: Cook Urological Inc. open end ureteral catheter 5FR, Karl Storz cystoscope 19-22F

06

What researchers measure

Primary outcomes

  1. Agreement between measurement of ureteral length (Centimeters) measured by CT and by ureteral catheterization

    Time frame: 1 year

07

Study locations

1 site
  • Carmel Medical Center
    Haifa, 34362, Israel
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 30, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01542593
Lead sponsor
Carmel Medical Center
Responsible party
Yuval Freifeld (Resident , Urology Department, principal investigator, Medical doctor, Carmel Medical Center) — Principal investigator
First posted
Mar 2, 2012
Start date
Feb 2012
Primary completion
Mar 2015
Completion
Mar 2015
Last update
Apr 30, 2015

Study contacts

Yuval Freifeld, Dr.
principal investigator · Carmel Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion